Orchard Therapeutics plc

Biotechnology company · London, England, United Kingdom

Orchard Therapeutics plc is a biotechnology company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $34 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Orchard Therapeutics at a glance

Typebiotechnology company

HeadquartersLondon, England, United Kingdom

Earliest incorporation on record2018

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1748907

What does Orchard Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $34 million sold (2023).

Frequently asked questions about Orchard Therapeutics

Where is Orchard Therapeutics headquartered?

Orchard Therapeutics plc is headquartered in London, England, United Kingdom.

What does Orchard Therapeutics do?

Orchard Therapeutics plc is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Orchard Therapeutics founded?

The earliest incorporation on record for Orchard Therapeutics plc is in 2018, according to public company registers.

Similar companies

Immunocore Holdings plcAbingdon, England, United Kingdom
Adaptimmune Therapeutics PLCAbingdon, England, United Kingdom
binx health LtdTrowbridge, England, United Kingdom
Calcivis LtdEdinburgh, Scotland, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.